M. Naveau

Roles of yeast eIF 2 a and eIF 2 b subunits in the binding of the initiator methionyl-tRNA

Y. Mechulam, E. Schmitt, Christine Lazennec-Schurdevin, 2013 .

Eukaryotic and archaeal translation initiation factor 2: A heterotrimeric tRNA carrier

Y. Mechulam, E. Schmitt, M. Naveau, 2010, FEBS letters.

Identification of a New Phenotype of Tolerogenic Human Dendritic Cells Induced by Fungal Proteases from Aspergillus oryzae

M. Pallardy, P. Moingeon, L. Mascarell, 2011, The Journal of Immunology.

Identification of the cysteine protease Amb a 11 as a novel major allergen from short ragweed.

P. Moingeon, L. Mascarell, J. Bouley, 2015, The Journal of allergy and clinical immunology.

Isoniazid chemoprophylaxis of latent primary tuberculosis: in five trial centres in France from 1959 to 1969.

F. Lert, S. Perdrizet, M. Naveau, 1973, International journal of epidemiology.

Roles of yeast eIF2 (cid:11) and eIF2 (cid:12) subunits in the binding of the initiator methionyl-tRNA

Y. Mechulam, E. Schmitt, Étienne, 2018 .

Roles of yeast eIF2α and eIF2β subunits in the binding of the initiator methionyl-tRNA

Y. Mechulam, E. Schmitt, Christine Lazennec-Schurdevin, 2012, Nucleic acids research.

tRNA binding properties of eukaryotic translation initiation factor 2 from Encephalitozoon cuniculi.

Y. Mechulam, E. Schmitt, Christine Lazennec-Schurdevin, 2010, Biochemistry.

Successful administration of mitotane (O, p′-DDD) in pediatric oncology

F. Feutry, A. Defachelles, S. Mercier, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.